A. Ferrant
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
-
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 2
- Chronic Myeloid Leukemia Treatments 2
-
- Acute Lymphoblastic Leukemia research 1
- Palliative Care and End-of-Life Issues 1
- Co-authors
- Thomas C. Pearson (1 shared paper)Y Najean (1 shared paper)Giovanni Barosi (1 shared paper)J. A. Simpson (1 shared paper)S Chinn (1 shared paper)David Guthrie (1 shared paper)S. M. Lewis (1 shared paper)C. Vermylen (1 shared paper)
- Journals
- British Journal of Haematology (1 paper)Blood (1 paper)Annals of Hematology (1 paper)Leukemia & lymphoma (1 paper)Acta Clinica Belgica (1 paper)
- Partner nations
- BelgiumItalyNetherlands
In The Last Decade
A. Ferrant
5 papers receiving 299 citations
Peers
Comparison fields: 5 of 58
- Genetics 82
- Hematology 63
- Critical Care and Intensive Care Medicine 19
- Biochemistry 25
- Nephrology 15
Countries citing papers authored by A. Ferrant
This map shows the geographic impact of A. Ferrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ferrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ferrant more than expected).
Fields of papers citing papers by A. Ferrant
This network shows the impact of papers produced by A. Ferrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ferrant. The network helps show where A. Ferrant may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ferrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 259 | |
| 2 | 1994 | 50 | |
| 3 | 1993 | 3 | |
| 4 | Domperidone (R 33812) in the prophylactic treatment of chemotherapy-induced emesis. A multicentre evaluation. | 1978 | 2 |
| 5 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 2001 | 1 |
| 6 | 1973 | 0 |
About A. Ferrant
A. Ferrant is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Surgery, Otorhinolaryngology and Genetics, having authored 6 papers that have together received 315 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Body Composition Measurement Techniques (1 paper), Head and Neck Cancer Studies (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Nausea and vomiting management (1 paper) and Palliative Care and End-of-Life Issues (1 paper). The work is most often cited by research in Genetics (82 citations), Hematology (63 citations), Critical Care and Intensive Care Medicine (19 citations), Biochemistry (25 citations) and Nephrology (15 citations). A. Ferrant has collaborated with scholars based in Belgium, Italy and Netherlands. Frequent co-authors include Thomas C. Pearson, Y Najean, Giovanni Barosi, J. A. Simpson, S Chinn, David Guthrie, S. M. Lewis, C. Vermylen, Philippe Martiat and Jl. Michaux. Their work appears in journals such as British Journal of Haematology, Blood, Annals of Hematology, Leukemia & lymphoma and Acta Clinica Belgica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.